Form 4: Stoke Therapeutics' Chief Medical Officer Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Chief Medical Officer of Stoke Therapeutics, Barry Ticho, sold shares of common stock on May 1st and 2nd, 2025, under a pre-arranged 10b5-1 trading plan.
Summary
- Barry Ticho, the Chief Medical Officer of Stoke Therapeutics, sold shares of the company's common stock on May 1, 2025, and May 2, 2025.
- The sales were executed under a Rule 10b5-1 trading plan adopted on December 11, 2024.
- On May 1, 2025, 3,841 shares were sold at a price of $10 per share.
- On May 2, 2025, 22,790 shares were sold at a weighted average price of $10.0282, with individual prices ranging from $10.00 to $10.10 per share.
- Following these transactions, Ticho directly owns 33,998 shares of Stoke Therapeutics common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to insider trading. It doesn't inherently convey positive or negative sentiment about the company's prospects, but rather reports factual transactions. The sentiment is neutral.
Industry Context
This is a routine disclosure of insider trading activity. Insiders often use 10b5-1 plans to sell shares over time to avoid accusations of trading on material non-public information. The filing itself doesn't provide specific context related to Stoke Therapeutics' performance or industry trends.
Stakeholder Impact
- The stock sale by a high-ranking officer could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 2024-12-11 | Date of adoption of Rule 10b5-1 trading plan |
| 2025-05-01 | Date of first stock sale (3,841 shares at $10) |
| 2025-05-02 | Date of second stock sale (22,790 shares at weighted average price of $10.0282) |
| 2025-05-05 | Date of Form 4 filing |
Keywords
Stoke Therapeutics, STOK, Form 4, insider trading, Barry Ticho, Chief Medical Officer, Rule 10b5-1, stock sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.